ArticleBlood advances2024

Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma.

Alexandre V Hirayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.